4/A: BiomX Inc. Director Eddie Williams Corrects Error in Form 4 Filing Regarding Option Acquisition

Director Eddie Williams files an amended Form 4 to correct an administrative error in reporting the acquisition of common stock options.

Summary

• Eddie Williams, a director of BiomX Inc., filed an amendment to a previously submitted Form 4.
• The amendment corrects an error in Table II, Column 5, where the number of derivative securities acquired was incorrectly reported as disposed of (D) instead of acquired (A).
• The transaction involves common stock options with a strike price of $0.538.
• These options grant the right to buy 17,600 shares of BiomX Inc. common stock.
• The options vest over four years, with 25% vesting on April 14, 2026, and the remainder vesting in 12 equal quarterly installments over three years.
• The original transaction date was April 14, 2025.
• Following the transaction, Williams directly owns 17,600 derivative securities.

Sentiment

Score: 7

Explanation: The document is a routine correction of a regulatory filing, indicating standard corporate governance practices. The sentiment is neutral to slightly positive as it reflects transparency.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency in the market.

Stakeholder Impact

• The correction ensures accurate information is available to shareholders regarding insider ownership.

Key Dates

Keywords

Form 4, Amendment, Director, Eddie Williams, BiomX Inc., PHGE, Stock Options, Beneficial Ownership, SEC Filing